Study Evaluating Miricell Supplement Effects on Cellular Health and Aging in Adults Ages 40 to 70

What this Trial Is About

Researchers are evaluating a dietary supplement called Miricell to see if it supports cellular health and healthy aging in adults aged 40 to 70. The trial aims to learn if Miricell improves autophagy, the bodys natural process for recycling damaged cells, and whether it benefits brain health, metabolic health, and visible signs of aging. The study also monitors any medical problems participants may experience while taking Miricell compared to a placebo. Participants are randomly assigned to take either one capsule of Miricell, which contains a standardized spermidine ingredient, or a placebo capsule each day for 12 weeks. Both capsules look identical to keep the study double-blind. Participants follow strict dietary guidelines to maintain consistent intake of polyamine-rich foods and other lifestyle habits to minimize variables. They take the capsules with a morning meal and follow specific fasting and diet instructions before scheduled lab visits. During the study, participants visit the research clinic four times for checkups and tests. They complete memory and thinking assessments, track daily physical activity, and provide blood samples at baseline, week 6, and week 12 to measure markers like serum Beclin-1 and ULK1 concentrations. Safety is closely monitored, with adverse events evaluated by medical staff. The total participation lasts for 12 weeks, with continuous monitoring to ensure protocol compliance and data quality.

Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy